DOB-FLY

DOB-FLY (or 2,5-dimethoxy-4-bromoamphetamine-fly) is a psychedelic drug that is part of the substituted amphetamine class. It is known for its hallucinogenic effects, which are similar to those of other psychedelic drugs such as LSD and psilocybin.

History

DOB-FLY was first synthesized in the late 20th century, following the discovery of its parent compound, DOB. The addition of the "FLY" moiety was intended to enhance the drug's psychedelic properties.

Pharmacology

Like other substituted amphetamines, DOB-FLY acts primarily as a serotonin receptor agonist. It binds to and activates the serotonin 2A receptor, which is thought to be primarily responsible for its psychedelic effects.

Effects

The effects of DOB-FLY are similar to those of other psychedelic drugs. Users often report intense visual hallucinations, altered thought processes, and a heightened sense of empathy. However, like all psychedelic drugs, the effects can vary greatly depending on the individual and the context in which the drug is used.

Legal Status

The legal status of DOB-FLY varies by country. In many places, it is classified as a controlled substance, making its manufacture, distribution, and use illegal. However, in some countries, it is legal for use in scientific research.

Risks

As with all psychedelic drugs, there are risks associated with the use of DOB-FLY. These can include psychological distress, dangerous behavior, and physical harm due to the drug's effects on perception and judgment. Long-term use can also lead to psychological dependence.

See Also

• Substituted amphetamines
• Psychedelic drugs
• Serotonin receptor agonists

• 
  Structure of DOB-FLY
• 
  DOB-FLY